Risk factors for atherosclerotic and medial arterial calcification of the intracranial internal carotid artery

Autor: Majoie, C.B., Roos, Y.B., Duijm, L.E., Keizer, K., van der Lugt, A., Dippel, D.W., Droogh-de Greve, K.E., Bienfait, H.P., van Walderveen, M.A., Wermer, M.J.H., Lycklama à Nijeholt, G.J., Boiten, J., Duyndam, D., Kwa, V.I., Meijer, F.J., van Dijk, E.J., Kesselring, F.O., Hofmeijer, J., Vos, J.A., Schonewille, W.J., van Rooij, W.J., de Kort, P.L., Pleiter, C.C., Bakker, S.L., Bot, J., Visser, M.C., Velthuis, B.K., van der Schaaf, I.C., Dankbaar, J.W., Mali, W.P., van Seeters, T., Horsch, A.D., Niesten, J.M., Biessels, G.J., Kappelle, L.J., Luitse, M.J., van der Graaf, Y., Vos, Annelotte, Kockelkoren, Remko, de Vis, Jill B., van der Schouw, Yvonne T., van der Schaaf, Irene C., Velthuis, Birgitta K., Mali, Willem P.T.M., de Jong, Pim A.

Publikováno v: In Atherosclerosis September 2018 276:44-49

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion

Autor: Langezaal, L.C.M., Hoeven, E.J.R.J. van der, Mont'Alverne, F.J.A., Carvalho, J.J.F. de, Lima, F.O., Dippel, D.W.J., Lugt, A. van der, R.T.H. lo, Boiten, J., Nijeholt, G.J.L.A., Staals, J., Zwam, W.H. van, Nederkoorn, P.J., Majoie, C.B.L.M., Gerber, J.C., Mazighi, M., Piotin, M., Zini, A., Vallone, S., Hofmeijer, J., Martins, S.O., Nolte, C.H., Szabo, K., Dias, F.A., Abud, D.G., Wermer, M.J.H., Remmers, M.J.M., Schneider, H., Rueckert, C.M., Laat, K.F. de, Yoo, A.J., Doormaal, P.J. van, Es, A.C.G.M. van, Emmer, B.J., Michel, P., Puetz, V., Audebert, H.J., Pontes-Neto, O.M., Vos, J.A., Kappelle, L.J., Algra, A., Schonewille, W.J., BASICS Study Grp

Publikováno v: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
New England Journal of Medicine, 384(20), 1910-1920. MASSACHUSETTS MEDICAL SOCIETY
New England journal of medicine, 384(20), 1910-1920. Massachussetts Medical Society
New England Journal of Medicine, 384(20), 1910-1920. MASSACHUSETTS MEDICAL SOC
New England Journal of Medicine, 384(20), 1910-1920. Massachussetts Medical Society

Background The effectiveness of endovascular therapy in patients with stroke caused by basilar-artery occlusion has not been well studied.Methods We randomly assigned patients within 6 hours after the estimated time of onset of a stroke due to basila

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76f34f958640d890fcee98fb3155c23f
https://doi.org/10.1056/nejmoa2030297

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED):an open-label, multicentre, randomised controlled trial

Autor: Steen, W. van der, Graaf, R.A.V. de, Chalos, V., Lingsma, H.F., Doormaal, P.J. van, Coutinho, J.M., Emmer, B.J., Ridder, I. de, Zwam, W. van, Worp, H.B. van der, Schaaf, I. van der, Gons, R.A.R., Yo, L.S.F., Boiten, J., Wijngaard, I. van den, Hofmeijer, J., Martens, J., Schonewille, W., Vos, J.A., Tuladhar, A.M., Laat, K.F. de, Hasselt, B. van, Remmers, M., Vos, D., Rozeman, A., Elgersma, O., Uyttenboogaart, M., Bokkers, R.P.H., Tuijl, J. van, Boukrab, I., Berg, R. van den, Beenen, L.F.M., Roosendaal, S.D., Postma, A.A., Krietemeijer, M., Lycklama, G., Meijer, F.J.A., Hammer, S., Hoorn, A. van der, Yoo, A.J., Gerrits, D., Truijman, M.T.B., Zinkstok, S., Koudstaal, P.J., Manschot, S., Kerkhoff, H., Nieboer, D., Berkhemer, O., Wolff, L., Sluijs, P.M. van der, Voorst, H. van, Tolhuisen, M., Roos, Y.B.W.E.M., Majoie, C.B.L.M., Staals, J., Oostenbrugge, R.J. van, Jenniskens, S.F.M., Dijk, L.C. van, Hertog, H.M. den, Es, A.C.G.M. van, Lugt, A. van der, Dippel, D.W.J., Roozenbeek, B., MR CLEAN-MED Investigators

Publikováno v: MR CLEAN-MED Investigators 2022, ' Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED) : an open-label, multicentre, randomised controlled trial ', The Lancet, vol. 399, no. 10329, pp. 1059-1069 . https://doi.org/10.1016/S0140-6736(22)00014-9
The Lancet, 399(10329), 1059-1069. ELSEVIER SCIENCE INC
The Lancet (London), 399, 1059-1069
The Lancet, 399(10329), 1059-1069. Elsevier Limited
The Lancet, 399(10329), 1059-1069. Elsevier Ltd.
The Lancet (London), 399, 10329, pp. 1059-1069
Lancet, 399(10329), 1059-1069. Elsevier Science

BACKGROUND: Aspirin and unfractionated heparin are often used during endovascular stroke treatment to improve reperfusion and outcomes. However, the effects and risks of anti-thrombotics for this indication are unknown. We therefore aimed to assess t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8953cfdde4fc4e0b25a24d129984fa64
https://research.vumc.nl/en/publications/155f1e87-ba12-4257-8269-1662795d2460